Tandem Diabetes Care annual operating margin
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Tandem Diabetes Care's operating margin was −18.45% for fiscal 2025.
View full Tandem Diabetes Care company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −18.45% | −7.91 pp |
| 2024 | 2024-12-31 | −10.54% | +20.65 pp |
| 2023 | 2023-12-31 | −31.19% | −19.60 pp |
| 2022 | 2022-12-31 | −11.59% | −14.81 pp |
| 2021 | 2021-12-31 | 3.22% | +4.82 pp |
| 2020 | 2020-12-31 | −1.60% | +3.02 pp |
| 2019 | 2019-12-31 | −4.62% | +19.66 pp |
| 2018 | 2018-12-31 | −24.27% | +34.22 pp |
| 2017 | 2017-12-31 | −58.50% | +34.15 pp |
| 2016 | 2016-12-31 | −92.64% | +2.08 pp |
| 2015 | 2015-12-31 | −94.72% | +57.45 pp |
| 2014 | 2014-12-31 | −152.17% | +18.25 pp |
| 2013 | 2013-12-31 | −170.42% | +1164.85 pp |
| 2012 | 2012-12-31 | −1,335.27% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −5.42% | +16.11 pp |
| Q1 2026 | 2026-03-31 | −7.05% | +44.51 pp |
| Q4 2025 | 2025-12-31 | 2.86% | +3.06 pp |
| Q3 2025 | 2025-09-30 | −9.17% | +1.52 pp |
| Q2 2025 | 2025-06-30 | −21.53% | −7.66 pp |
| Q1 2025 | 2025-03-31 | −51.56% | −29.82 pp |
| Q4 2024 | 2024-12-31 | −0.21% | +17.61 pp |
| Q3 2024 | 2024-09-30 | −10.70% | +6.30 pp |
| Q2 2024 | 2024-06-30 | −13.87% | +5.94 pp |
| Q1 2024 | 2024-03-31 | −21.74% | +53.72 pp |
| Q4 2023 | 2023-12-31 | −17.82% | −9.75 pp |
| Q3 2023 | 2023-09-30 | −16.99% | +6.22 pp |
| Q2 2023 | 2023-06-30 | −19.81% | −13.70 pp |
| Q1 2023 | 2023-03-31 | −75.46% | −66.74 pp |
| Q4 2022 | 2022-12-31 | −8.06% | −14.13 pp |
| Q3 2022 | 2022-09-30 | −23.22% | −27.52 pp |
| Q2 2022 | 2022-06-30 | −6.11% | −9.27 pp |
| Q1 2022 | 2022-03-31 | −8.72% | −6.42 pp |
| Q4 2021 | 2021-12-31 | 6.07% | −5.04 pp |
| Q3 2021 | 2021-09-30 | 4.30% | +5.11 pp |
| Q2 2021 | 2021-06-30 | 3.16% | +14.17 pp |
| Q1 2021 | 2021-03-31 | −2.30% | +11.57 pp |
| Q4 2020 | 2020-12-31 | 11.10% | +9.13 pp |
| Q3 2020 | 2020-09-30 | −0.82% | +5.53 pp |
| Q2 2020 | 2020-06-30 | −11.02% | −9.02 pp |
| Q1 2020 | 2020-03-31 | −13.86% | +2.80 pp |
| Q4 2019 | 2019-12-31 | 1.98% | +1.24 pp |
| Q3 2019 | 2019-09-30 | −6.34% | +27.61 pp |
| Q2 2019 | 2019-06-30 | −2.00% | +39.02 pp |
| Q1 2019 | 2019-03-31 | −16.66% | +40.11 pp |
| Q4 2018 | 2018-12-31 | 0.73% | +24.52 pp |
| Q3 2018 | 2018-09-30 | −33.96% | +14.81 pp |
| Q2 2018 | 2018-06-30 | −41.02% | +47.92 pp |
| Q1 2018 | 2018-03-31 | −56.77% | +55.08 pp |
| Q4 2017 | 2017-12-31 | −23.78% | +22.38 pp |
| Q3 2017 | 2017-09-30 | −48.76% | +182.38 pp |
| Q2 2017 | 2017-06-30 | −88.94% | −14.75 pp |
| Q1 2017 | 2017-03-31 | −111.85% | −15.94 pp |
| Q4 2016 | 2016-12-31 | −46.16% | −7.63 pp |
| Q3 2016 | 2016-09-30 | −231.14% | −112.13 pp |
| Q2 2016 | 2016-06-30 | −74.19% | +44.69 pp |
| Q1 2016 | 2016-03-31 | −95.91% | +69.92 pp |
| Q4 2015 | 2015-12-31 | −38.53% | +59.31 pp |
| Q3 2015 | 2015-09-30 | −119.01% | +21.63 pp |
| Q2 2015 | 2015-06-30 | −118.88% | +59.75 pp |
| Q1 2015 | 2015-03-31 | −165.83% | +92.55 pp |
| Q4 2014 | 2014-12-31 | −97.84% | +62.86 pp |
| Q3 2014 | 2014-09-30 | −140.64% | +15.32 pp |
| Q2 2014 | 2014-06-30 | −178.63% | +68.80 pp |
| Q1 2014 | 2014-03-31 | −258.38% | −127.09 pp |
| Q4 2013 | 2013-12-31 | −160.70% | — |
| Q3 2013 | 2013-09-30 | −155.96% | — |
| Q2 2013 | 2013-06-30 | −247.43% | — |
| Q1 2013 | 2013-03-31 | −131.29% | — |
Over the last five reported fiscal years, Tandem Diabetes Care's operating margin decreased from −1.60% to −18.45%, a change of −16.86 percentage points. The latest reported quarter, Q2 2026, shows −5.42%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tandem Diabetes Care filings at SEC.gov ↗